March 30 (Reuters) - Lipella Pharmaceuticals Inc LIPO.PK:
LIPELLA PHARMACEUTICALS INC. FILES VOLUNTARY PETITIONS FOR RELIEF UNDER CHAPTER 11
LIPELLA PHARMACEUTICALS INC: INTENDS TO UNDERGO A 363 SALE PROCESS UNDER CHAPTER 11
LIPELLA PHARMACEUTICALS INC: EXPECTS TO SEEK CUSTOMARY "FIRST-DAY" RELIEF THAT, IF APPROVED BY COURT, WOULD ALLOW IT TO CONTINUE DAY-TO-DAY OPERATIONS
Source text: ID:nGNXbz4d0Z
Further company coverage: LIPO.PK
((Reuters.briefs@thomsonreuters.com;))
At the request of the copyright holder, you need to log in to view this content
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments